NCT00683865 - Uncomplicated Pelvic Inflammatory Disease. Treatment With Moxifloxacin. | Biotech Hunter

Enrollment

749

Participants

Timeline

Start Date

April 30, 2003

Primary Completion Date

October 31, 2004

Study Completion Date

October 31, 2004

Conditions

Pelvic Inflammatory Disease

Interventions

DRUG

Ofloxacin

Ofloxacin 400 mg po bid plus metronidazole 500 mg po bid for 14 days

DRUG

Avelox (Moxifloxacin, BAY12-8039)

Moxifloxacin 400 mg po od for 14 days

Trial Locations (77)

1115

Budapest

1804

Johannesburg

2132

Johannesburg

2650

Hvidovre

3301

Eger

4001

Durban

6000

Kecskemét

7505

Cape Town

9024

Győr

9300

Bloemfontein

10117

Berlin

10249

Berlin

11528

Athens

13530

Hämeenlinna

18057

Rostock

19100

Brive-la-Gaillarde

27100

Pavia

31059

Toulouse

31600

Muret

33000

Bordeaux

33150

Cenon

34059

Montpellier

34137

Trieste

41515

Grevenbroich

42103

Wuppertal

45257

Essen

45500

Dourouti-Ioannina

48210

Kotka

51375

Leverkusen

54045

Nancy

59037

Lille

63110

Beaumont

75009

Paris

75020

Paris

80210

Joensuu

80336

München

82000

Montauban

92166

Antony

92288

Klaipėda

92701

Colombes

94010

Créteil

95330

Domont

107076

Moscow

117049

Moscow

117997

Moscow

DK-5000

Odense C

DK-4000

Roskilde

00029

Helsinki

115 21

Athens

H-1085

Budapest

06122

Perugia

LT-04130

Vilnius

LT-2000

Vilnius

LT-2021

Vilnius

15-276

Bialystok

30-501

Krakow

93-338

Lodz

20-090

Lublin

05-400

Owock

61-701

Poznan

00-416

Warsaw

00-909

Warsaw

0001

Pretoria

Unknown

Pretoria

Cape Town

413 45

Gothenburg

581 85

Linköping

221 85

Lund

461 85

Trollhättan

432 81

Varberg

BS2 8HW

Bristol

SW10 9NH

London

SW17 0QT

London

WC1E 6AU

London

SO14 0YG

Southampton

NG5 1PB

Nottingham

B4 6DH

Birmingham